Sambugaro, R <br/><br/>
The efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase.  [electronic resource] 

 -  Allergologia et immunopathologia   
 - 329-37 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0301-0546 
<br/><br/><label>Standard No.: </label>10.1016/s0301-0546(03)79207-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adolescent<br/>Adult<br/>Allergens--administration & dosage<br/>Asthma--therapy<br/>Child<br/>Child, Preschool<br/>Conjunctivitis, Allergic--therapy<br/>Desensitization, Immunologic--methods<br/>Dose-Response Relationship, Immunologic<br/>Drug Administration Schedule<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Male<br/>Rhinitis, Allergic, Perennial--therapy<br/>Rhinitis, Allergic, Seasonal--therapy<br/>Safety<br/>Skin Tests<br/>Treatment Outcome